Rayonier Inc (RYN)
Official siteREAL ESTATE • REIT - SPECIALTY • NYSE
Market Cap: $6.33B
Last updated: Nov 17, 2026 at 4:18 PM ET
Rayonier Inc (RYN) Stock Chart
Rayonier (RYN) has a latest price of $20.86 on Nov 17, 2026, 12.7% below its 52-week high of $23.90. Its price fell 1.9% over the past 12 months. The month-end price fell 27.7% over the 10 years through Oct 2026, a compound annual decline of 3.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $43.20 in Apr 2022 and its lowest $18.36 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RYN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RYN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 1.6%, and over 6 months it rose 7.1%. The month-end price fell 23.2% over the 3 years through Oct 2026, a compound annual decline of 8.4%.
| Period | Change |
|---|---|
| 1 month | +11.6% |
| 3 months | -1.6% |
| 6 months | +7.1% |
| 12 months | -1.9% |
| 12 months, with dividends | +3.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -23.2% | -8.4% |
| 5 years | -48.1% | -12.3% |
| 10 years | -27.7% | -3.2% |
Price by Year
Its best calendar year was 2021, when the price rose 37.4%, and its weakest was 2024, when it fell 21.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $19.38 | -10.5% |
| 2025 | $21.65 | -17.0% |
| 2024 | $26.10 | -21.9% |
| 2023 | $33.41 | +1.4% |
| 2022 | $32.96 | -18.3% |
| 2021 | $40.36 | +37.4% |
| 2020 | $29.38 | -10.3% |
| 2019 | $32.76 | +18.3% |
| 2018 | $27.69 | -12.5% |
| 2017 | $31.63 | +18.9% |
Trading Range
The price is 6.6% above its 50-day average of $19.57 and 1.7% above its 200-day average of $20.52.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $20.86 | |
| 52-week high | $23.90 | -12.7% |
| 52-week low | $17.71 | +17.8% |
| 50-day average | $19.57 | +6.6% |
| 200-day average | $20.52 | +1.7% |
Price Risk
Over 3 years, its largest fall from a peak was 41.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.03 |
| Largest fall, 1 year | -26.1% |
| Largest fall, 3 years | -41.4% |
Valuation
Rayonier is valued on funds from operations, at 25.4x its 2026 FFO estimate.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RYN
What is RYN's 1-year price change?
Rayonier's price fell 1.9% over the past 12 months. With dividends included, the 12-month total return was 3.1%.
What is RYN's 5-year price change?
Rayonier's month-end price fell 48.1% over the 5 years through Oct 2026, a compound annual decline of 12.3%. These figures leave out dividends.
What is RYN's 52-week high and low?
Rayonier's 52-week high is $23.90 and its 52-week low is $17.71. Its latest price of $20.86 on Nov 17, 2026 is 12.7% below the high.
What is RYN's beta?
Rayonier's 1-year beta against the S&P 500 is 0.03, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 26.1%.
Is the RYN chart free?
Yes. Advanced Charting for RYN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RYN pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors